BioCentury | Oct 6, 2014
Company News

Caliber Biotherapeutics, Mapp Biopharmaceutical, U.S. Department of Health and Human Services infectious news

...been shown to reverse 100% of advanced Ebola cases in primates (see BioCentury, Sept. 8). Caliber Biotherapeutics LLC...
BioCentury | Oct 3, 2014
Company News

HHS seeks to boost ZMapp production

...HHS said it is in talks with biomanufacturing company Caliber Biotherapeutics LLC (Bryan, Texas) to produce the experimental...
BioCentury | Jan 20, 2014
Company News

Caliber Biotherapeutics, iBio deal

...under the deal. The partners did not disclose financial details (see BioCentury, Feb. 25, 2013). Caliber Biotherapeutics LLC...
BioCentury | Jul 1, 2013
Clinical News

Caliber Biotherapeutics, ImmunGene preclinical data

...Switzerland), co-market rituximab as Rituxan in the U.S., while Roche markets it as MabThera elsewhere. Caliber Biotherapeutics LLC...
BioCentury | Jun 3, 2013
Company News

Caliber Biotherapeutics, ImmunGene, LLS cancer news

...approved to treat first-line and relapsed chronic lymphocytic leukemia (CLL), NHL and rheumatoid arthritis (RA). Caliber Biotherapeutics LLC...
BioCentury | Feb 25, 2013
Company News

Caliber Biotherapeutics, iBio deal

...also make their combined capabilities available to third parties. The parties declined to provide details. Caliber Biotherapeutics LLC...
BioCentury | Nov 1, 2012
Strategy

Mess with Texas

...the company grants. Recipient Program Funding ($M) Cell Medica Ltd. Company relocation and recruitment 15.6 Caliber Biotherapeutics LLC...
Items per page:
1 - 7 of 7
BioCentury | Oct 6, 2014
Company News

Caliber Biotherapeutics, Mapp Biopharmaceutical, U.S. Department of Health and Human Services infectious news

...been shown to reverse 100% of advanced Ebola cases in primates (see BioCentury, Sept. 8). Caliber Biotherapeutics LLC...
BioCentury | Oct 3, 2014
Company News

HHS seeks to boost ZMapp production

...HHS said it is in talks with biomanufacturing company Caliber Biotherapeutics LLC (Bryan, Texas) to produce the experimental...
BioCentury | Jan 20, 2014
Company News

Caliber Biotherapeutics, iBio deal

...under the deal. The partners did not disclose financial details (see BioCentury, Feb. 25, 2013). Caliber Biotherapeutics LLC...
BioCentury | Jul 1, 2013
Clinical News

Caliber Biotherapeutics, ImmunGene preclinical data

...Switzerland), co-market rituximab as Rituxan in the U.S., while Roche markets it as MabThera elsewhere. Caliber Biotherapeutics LLC...
BioCentury | Jun 3, 2013
Company News

Caliber Biotherapeutics, ImmunGene, LLS cancer news

...approved to treat first-line and relapsed chronic lymphocytic leukemia (CLL), NHL and rheumatoid arthritis (RA). Caliber Biotherapeutics LLC...
BioCentury | Feb 25, 2013
Company News

Caliber Biotherapeutics, iBio deal

...also make their combined capabilities available to third parties. The parties declined to provide details. Caliber Biotherapeutics LLC...
BioCentury | Nov 1, 2012
Strategy

Mess with Texas

...the company grants. Recipient Program Funding ($M) Cell Medica Ltd. Company relocation and recruitment 15.6 Caliber Biotherapeutics LLC...
Items per page:
1 - 7 of 7